CLINICAL CASE OF TOCILIZUMAB THERAPY IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

E. I. Alexeeva; E. I. Alexeeva; R. V. Denisova; T. V. Sleptsova

doi:10.15690/pf.v10i4.771

Педиатрическая фармакология (Jul 2013)

CLINICAL CASE OF TOCILIZUMAB THERAPY IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

E. I. Alexeeva,
E. I. Alexeeva,
R. V. Denisova,
T. V. Sleptsova

Affiliations

E. I. Alexeeva: Scientific Center of Children’s Health, Moscow The First Sechenov Moscow State Medical University
E. I. Alexeeva: Scientific Center of Children’s Health, Moscow, Russian Federation The First Sechenov Moscow State Medical University, Russian Federation
R. V. Denisova: Scientific Center of Children’s Health, Moscow, Russian Federation
T. V. Sleptsova: Scientific Center of Children’s Health, Moscow, Russian Federation

DOI: https://doi.org/10.15690/pf.v10i4.771
Journal volume & issue: Vol. 10, no. 4
pp. 154 – 158

Abstract

Read online

The article presents a case of successful application of a monoclonal antibodies drug to interleukin 6 receptors (tocilizumab) at severe systemic juvenile idiopathic arthritis with the development of secondary hemophagocytic syndrome. Tocilizumab treatment secured a decrease in clinical and laboratory parameters of the disease activity, life quality improvement, systemic juvenile idiopathic arthritis and hemophagocytic syndrome remission and allowed avoiding the per os prescription of glucocorticoids.

Published in Педиатрическая фармакология

ISSN: 1727-5776 (Print); 2500-3089 (Online)
Publisher: Union of pediatricians of Russia
Country of publisher: Russian Federation
LCC subjects: Medicine: Pediatrics; Medicine: Therapeutics. Pharmacology
Website: https://www.pedpharma.ru/

About the journal

Abstract

Keywords